182 related articles for article (PubMed ID: 33082498)
1. Paradoxical risk of reduced fertility after exposure of prepubertal mice to vincristine or cyclophosphamide at low gonadotoxic doses in humans.
Delessard M; Saulnier J; Dumont L; Rives-Feraille A; Rives N; Rondanino C
Sci Rep; 2020 Oct; 10(1):17859. PubMed ID: 33082498
[TBL] [Abstract][Full Text] [Related]
2. The impact of vincristine on testicular development and function in childhood cancer.
Clark I; Brougham MFH; Spears N; Mitchell RT
Hum Reprod Update; 2023 Mar; 29(2):233-245. PubMed ID: 36495566
[TBL] [Abstract][Full Text] [Related]
3. Achievement of complete in vitro spermatogenesis in testicular tissues from prepubertal mice exposed to mono- or polychemotherapy.
Delessard M; Stalin L; Rives-Feraille A; Moutard L; Saulnier J; Dumont L; Rives N; Rondanino C
Sci Rep; 2022 May; 12(1):7407. PubMed ID: 35523907
[TBL] [Abstract][Full Text] [Related]
4. Early prepubertal cyclophosphamide exposure in mice results in long-term loss of ovarian reserve, and impaired embryonic development and blastocyst quality.
Salian SR; Uppangala S; Cheredath A; D'Souza F; Kalthur G; Nayak VC; Anderson RA; Adiga SK
PLoS One; 2020; 15(6):e0235140. PubMed ID: 32574203
[TBL] [Abstract][Full Text] [Related]
5. Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase.
Medrano JV; Hervás D; Vilanova-Pérez T; Navarro-Gomezlechon A; Goossens E; Pellicer A; Andrés MM; Novella-Maestre E
Reprod Sci; 2021 Feb; 28(2):603-613. PubMed ID: 33150486
[TBL] [Abstract][Full Text] [Related]
6. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature.
Deutschbein T; Fassnacht M; Weismann D; Reincke M; Mann K; Petersenn S
Clin Endocrinol (Oxf); 2015 Jan; 82(1):84-90. PubMed ID: 25143180
[TBL] [Abstract][Full Text] [Related]
8. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.
Sonigo C; Beau I; Grynberg M; Binart N
FASEB J; 2019 Jan; 33(1):1278-1287. PubMed ID: 30113879
[TBL] [Abstract][Full Text] [Related]
9. Fertility in males treated for Hodgkins disease with COPP/ABV hybrid.
Hobbie WL; Ginsberg JP; Ogle SK; Carlson CA; Meadows AT
Pediatr Blood Cancer; 2005 Feb; 44(2):193-6. PubMed ID: 15390272
[TBL] [Abstract][Full Text] [Related]
10. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility.
Nurmio M; Keros V; Lähteenmäki P; Salmi T; Kallajoki M; Jahnukainen K
J Clin Endocrinol Metab; 2009 Jun; 94(6):2119-22. PubMed ID: 19318447
[TBL] [Abstract][Full Text] [Related]
11. In vitro formation of the blood-testis barrier during long-term organotypic culture of human prepubertal tissue: comparison with a large cohort of pre/peripubertal boys.
de Michele F; Poels J; Giudice MG; De Smedt F; Ambroise J; Vermeulen M; Gruson D; Wyns C
Mol Hum Reprod; 2018 May; 24(5):271-282. PubMed ID: 29538744
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the antifertility effects of alkylating agents and vinca alkaloids in male rats.
Cooke RA; Nikles A; Roeser HP
Br J Pharmacol; 1978 Aug; 63(4):677-81. PubMed ID: 687878
[TBL] [Abstract][Full Text] [Related]
13. Low-dose metronomic delivery of cyclophosphamide is less detrimental to granulosa cell viability, ovarian function, and fertility than maximum tolerated dose delivery in the mouse.
Dynes J; Osz K; Hooper A; Petrik J
Biol Reprod; 2017 Sep; 97(3):449-465. PubMed ID: 29024988
[TBL] [Abstract][Full Text] [Related]
14. Chronic cyclophosphamide treatment alters the expression of stress response genes in rat male germ cells.
Aguilar-Mahecha A; Hales BF; Robaire B
Biol Reprod; 2002 Apr; 66(4):1024-32. PubMed ID: 11906922
[TBL] [Abstract][Full Text] [Related]
15. Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure.
Codrington AM; Hales BF; Robaire B
J Androl; 2004; 25(3):354-62. PubMed ID: 15064312
[TBL] [Abstract][Full Text] [Related]
16. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
[TBL] [Abstract][Full Text] [Related]
17. Tissue Engineering to Improve Immature Testicular Tissue and Cell Transplantation Outcomes: One Step Closer to Fertility Restoration for Prepubertal Boys Exposed to Gonadotoxic Treatments.
Del Vento F; Vermeulen M; de Michele F; Giudice MG; Poels J; des Rieux A; Wyns C
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29346308
[TBL] [Abstract][Full Text] [Related]
18. Effects of the chemotherapeutic agents for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome.
Vaisheva F; Delbes G; Hales BF; Robaire B
J Androl; 2007; 28(4):578-87. PubMed ID: 17409468
[TBL] [Abstract][Full Text] [Related]
19. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood.
Kenney LB; Laufer MR; Grant FD; Grier H; Diller L
Cancer; 2001 Feb; 91(3):613-21. PubMed ID: 11169946
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats.
Tsuyoshi H; Orisaka M; Fukuda S; Hattori K; Tsang BK; Yoshida Y
Steroids; 2015 Jan; 93():1-7. PubMed ID: 25449767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
